Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Scientists in many countries are working on vaccines to treat cancer, and more traditional vaccines protect against cancer-causing viruses.
Study suggests greater CD8 T-cell activity may increase HIV immunity.
The PrEPVacc trial is unlikely to show that experimental vaccine regimens can prevent HIV.
While IAS is disappointed at this outcome, we believe that this provides us with lessons to drive HIV vaccine R&D with urgency.
The live-attenuated vaccine aims to produce an immune response to the entire virus rather than the frequently mutating spike protein.
The technology, developed by Katalin Karikó and Drew Weissman, also holds promise for HIV vaccines and cancer treatment.
The vaccine, dubbed VIR-1388, is designed to stimulate the production of T cells to fight HIV.
U.S. syphilis incidence has increased since 2000, with an escalating toll in medically underserved populations.
Herpes simplex can be treated with antivirals, but there is no vaccine or cure.
The most common symptoms of meningococcal meningitis are fever, headache and a stiff neck.
Researchers are working on vaccines that will target multiple flu or coronavirus strains.
Researchers are working on a cure for hepatitis B and a vaccine and long-acting antivirals for hepatitis C.
TB is one of the world’s deadliest diseases and the leading killer of people with HIV.
The experimental vaccine regimen trains the immune system to produce broadly neutralizing antibodies that target HIV.
The Jynneos monkeypox vaccine is highly effective, but two doses are needed for optimal protection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.